Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable doxycycline after rhinoplasty
IRCT20241028063528N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of doxycycline (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Skin thickness, Skin type and 2 more. Started Nov 2024; status: completed.
02
Drugs
doxycycline
Beyond the preview
Go deeper on IRCT20241028063528N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241028063528N1.